[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f1rur_-J56xT-vcviGzFVbRbNTULUmctkx2vaGMDwuJU":8,"$fWQsnvxOy_d41VZnf95I4brQzhJqm3cJ_6anLSy6Ygoc":56,"$fNeAXVRV4Ypith3vBV0i5A1_MdVzYIttQSKCo_EWHzqI":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":21,"menus":33,"menuId":35,"type":43,"quality":54,"commentCount":21,"isComment":43},18765,867103,[],"https://ystcdn.venuertc.com/medical/ystApp/C85kRC6RoqqjiNPDDfiZya6XrPBEuuWv.png","赵光磊","临沭县人民医院","肿瘤科","主治医师",99,0,"震惊！您知道肝癌晚期到底有多可怕吗？——一篇关于肝癌晚期的必读科普","","https://ystcdn.venuertc.com/venue/AI/29249855-0fad-4af6-adde-7f2403ef54d5.jpg","\u003Cp style=\"margin:15px 0\">肝癌——这个词可能听上去遥远且恐怖，但你知道吗？在我们身边，肝癌患者的数量正在逐年增加，特别是晚期肝癌，对患者和家庭的打击是巨大的。那么，肝癌晚期到底是什么样的，它的危害有多大，又该如何预防呢？本文将为您详细解答。\u003C/p>\u003Cp style=\"margin:15px 0\">根据国家癌症中心的数据显示，中国每年新增肝癌病例近40万，死亡人数也在30万左右，居全球第一。肝癌在中国的发病率和死亡率非常高，其原因众多，包括乙型肝炎病毒感染、丙型肝炎病毒感染、肝硬化、脂肪肝等因素，这些都大大增加了患上肝癌的风险。为了让大家更好地了解肝癌，下面我们将详细探讨。\u003C/p>\u003Ch3 style=\"margin:20px 0\">肝癌晚期：生存期短，疼痛难忍\u003C/h3>\u003Cp style=\"margin:15px 0\">肝癌晚期意味着什么？这是一种在肝脏中生长的恶性肿瘤，已经发展到不可手术切除的阶段。肝脏是人体的重要器官，负责排毒和代谢，如果肝脏功能受损，整个身体都会产生严重的影响。\u003C/p>\u003Cp style=\"margin:15px 0\">在肝癌晚期，常见的症状包括腹部疼痛、黄疸、腹水、体重迅速下降等。来自《Journal of Hepatology》的研究表明，晚期肝癌患者的平均生存期仅为6到12个月。患者常常面临剧烈的疼痛和各种并发症，如出血、感染、肝性脑病等，这些都会进一步缩短生存时间，提高死亡率。\u003C/p>\u003Ch3 style=\"margin:20px 0\">晚期肝癌：如何治疗？\u003C/h3>\u003Cp style=\"margin:15px 0\">尽管晚期肝癌的治疗具有相当的挑战性，但并不意味着没有希望。现代医学提供了一些主要的治疗方法，帮助延长患者的生存期，提高生活质量。\u003C/p>\u003Cp style=\"margin:15px 0\">首先是系统性治疗，其中包括靶向治疗和免疫治疗。靶向治疗如索拉非尼（Sorafenib），通过抑制癌细胞的生长和扩散，已经证明可以显著延长部分晚期肝癌患者的生存期。免疫治疗则通过激活患者自身的免疫系统来攻击癌细胞，如PD-1抑制剂。\u003C/p>\u003Cp style=\"margin:15px 0\">其次是局部治疗，如肝动脉化疗栓塞术（TACE），通过向肝脏肿瘤处注入化疗药物并阻断血供，来抑制肿瘤生长。此外，放射治疗也是一个常见的选择，特别是对那些不能手术的患者。\u003C/p>\u003Ch3 style=\"margin:20px 0\">肝癌高危人群如何预防？\u003C/h3>\u003Cp style=\"margin:15px 0\">预防肝癌，特别是高危人群，需要采取多种措施。首先是接种乙型肝炎疫苗，可以显著减少未来患肝癌的风险。其次是定期体检，早发现早治疗，对于乙型肝炎、丙型肝炎患者，应进行密切的监控和及时的抗病毒治疗。\u003C/p>\u003Cp style=\"margin:15px 0\">饮酒和肥胖也是肝癌的重要危险因素。根据《The Lancet Gastroenterology & Hepatology》的研究报告，长期饮酒会显著增加患肝癌的风险，而肥胖和代谢综合征也与肝癌的发生密切相关。因此，减少饮酒和控制体重对于预防肝癌至关重要。\u003C/p>\u003Ch3 style=\"margin:20px 0\">展望未来：肝癌治疗的新方向\u003C/h3>\u003Cp style=\"margin:15px 0\">随着医学技术的不断进步，肝癌的治疗方法也在不断更新和完善。除了现有的系统性治疗和局部治疗外，基因治疗和精准医学将成为未来肝癌治疗的主要方向。通过基因检测，了解患者肿瘤的分子特性，针对性地制定治疗方案，已经在多个临床试验中显示出良好的效果。\u003C/p>\u003Cp style=\"margin:15px 0\">此外，早期诊断技术的提升，如液体活检和高分辨率成像技术，有望进一步提高肝癌的早期发现率，从而显著提高治疗效果。\u003C/p>\u003Cp style=\"margin:15px 0\">总而言之，肝癌，特别是晚期肝癌，给患者和家庭带来巨大的痛苦。但通过科学的预防和合理的治疗，可以在一定程度上控制病情，延长患者的生存期。希望大家能重视肝癌的防治，提高健康意识，远离肝癌的困扰。\u003C/p>\u003Ch3 style=\"margin:20px 0\">参考文献\u003C/h3>\u003Col style=\"padding: 0 1rem;margin: 1.25rem 1rem 1.25rem 0.4rem\">\u003Cli>\u003Cp style=\"margin:15px 0\">Chen JG, Zhang SW. Liver cancer epidemic in China: past, present and future. Semin Cancer Biol. 2011;21(1):59-69.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011 Mar;53(3):1020-2.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Robertson A, Sandler RS, Mehta SK. Screening for hepatocellular carcinoma. Gastroenterology. 2012 Jun;142(8):2144-5.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008 Jul 24;359(4):378-90.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002 Jul;35(5 Suppl 2):S72-8.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Abou-Alfa GK, Schwartz L, Ricci S, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006 Dec 1;24(26):4293-300.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Kelly RJ, Sharon E. Clinical utility and future directions of immune checkpoint inhibitors. J Clin Pharmacol. 2019;59(4):405-12.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009 Jan 15;115(2):5651-61.\u003C/p>\u003C/li>\u003C/ol>","\n\n肝癌——这个词可能听上去遥远且恐怖，但你知道吗？在我们身边，肝癌患者的数量正在逐年增加，特别是晚期肝癌，对患者和家庭的打击是巨大的。那么，肝癌晚期到底是什么样的，它的危害有多大，又该如何预防呢？本",510,"2025-04-09 14:43:13"," 震惊！您知道肝癌晚期到底有多可怕吗？——一篇关于肝癌晚期的必读科普"," 肝癌晚期, 肝癌症状, 肝癌治疗, 肝癌预防, 肝癌科普, 肝癌晚期可怕性"," 深入了解肝癌晚期的可怕之处，包括其症状、治疗方法及预防措施。本文为您提供全面的肝癌科普知识，帮助您更好地认识和应对这一严重疾病。","2025-04-24 23:25:00",[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":37,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普",2,"article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]